COVID-19相关急性呼吸衰竭非插管患者俯卧位通气的可行性与生理效应(PRON-COVID):一项前瞻性队列研究
这项前瞻性可行性队列研究在意大利蒙扎San Gerardo医院纳入56例18-75岁确诊COVID-19相关肺炎、接受补充氧疗或无创持续气道正压的清醒非插管患者,俯卧位维持至少3小时。主要结局为基线至翻身仰卧后氧合(PaO2/FiO2)变化:俯卧位期间PaO2/FiO2由仰卧位的180.5 mm Hg(SD 76.6)升至285.5 mm Hg(112.9)(p<0.0001),翻身仰卧1小时后为192.9 mm Hg(100.9),较俯卧位前平均未达统计学显著(p=0.29),仅50.0%患者维持改善。俯卧位可行率83.9%(95%CI 71.7-92.4),46例中13例(28%)最终插管,5例死亡与操作无关。作者认为俯卧位可行且能迅速改善氧合,但需进一步研究确认对最终呼吸与整体结局的潜在益处。
要点
- 清醒非插管COVID-19肺炎患者俯卧位可行率83.9%(95%CI 71.7-92.4),即47/56例维持至少3小时。
- 俯卧位期间PaO2/FiO2由仰卧位180.5 mm Hg(SD 76.6)升至285.5 mm Hg(112.9),p<0.0001。
- 翻身仰卧1小时后PaO2/FiO2为192.9 mm Hg(100.9),较俯卧位前平均未达统计学显著(p=0.29),仅50.0%(95%CI 34.9-65.1)患者维持氧合改善。
- 维持氧合改善者(responders)较未维持者(non-responders)C反应蛋白更高(12.7 mg/L [SD 6.9] vs 8.4 mg/L [6.2])、血小板更低(241.1×10³/μL [101.9] vs 319.8×10³/μL [120.6])、入院至俯卧位时间更短(2.7天 [SD 2.1] vs 4.6天 [3.7])。
- 46例中13例(28%)最终插管,responders 7/23(30%)vs non-responders 6/23(26%),p=0.74;5例死亡与操作无关。
适用人群与场景
- 18-75岁确诊COVID-19相关肺炎、接受补充氧疗或无创持续气道正压的清醒非插管患者,来自意大利蒙扎San Gerardo医院。
处置流程与药物剂量
- 基线数据采集后协助患者进入俯卧位,维持至少3小时;俯卧位后10分钟及翻身仰卧后1小时重新采集临床数据。
研究设计与关键结果
- 前瞻性可行性队列研究,纳入56例患者,44例(79%)为男性,平均年龄57.4岁(SD 7.4),平均BMI 27.5 kg/m²(3.7)。
- 俯卧位可行(维持至少3小时)47例(83.9% [95%CI 71.7-92.4])。
- PaO2/FiO2由仰卧位180.5 mm Hg(SD 76.6)升至俯卧位285.5 mm Hg(112.9),p<0.0001。
- 翻身仰卧1小时后PaO2/FiO2为192.9 mm Hg(100.9),较俯卧位前平均未达统计学显著(p=0.29);23例(50.0% [95%CI 34.9-65.1])维持氧合改善(responders)。
- Responders vs non-responders:C反应蛋白12.7 mg/L(SD 6.9)vs 8.4 mg/L(6.2);血小板241.1×10³/μL(101.9)vs 319.8×10³/μL(120.6);入院至俯卧位时间2.7天(SD 2.1)vs 4.6天(3.7)。
- 46例中13例(28%)最终插管:responders 7/23(30%)vs non-responders 6/23(26%),p=0.74。
- 5例在随访期间因基础疾病死亡,与研究操作无关。
证据类型、等级与局限
- 证据类型:前瞻性可行性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为俯卧位在需补充氧疗的清醒COVID-19相关肺炎患者中可行,并能迅速改善血氧;效果在半数患者翻身仰卧后维持。
- 作者认为需进一步研究以确认该技术对改善最终呼吸与整体结局的潜在益处。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The COVID-19 pandemic is challenging advanced health systems, which are dealing with an overwhelming number of patients in need of intensive care for respiratory failure, often requiring intubation. Prone positioning in intubated patients is known to reduce mortality in moderate-to-severe acute respiratory distress syndrome. We aimed to investigate feasibility and effect on gas exchange of prone positioning in awake, non-intubated patients with COVID-19-related pneumonia.
METHODS: In this prospective, feasibility, cohort study, patients aged 18-75 years with a confirmed diagnosis of COVID-19-related pneumonia receiving supplemental oxygen or non-invasive continuous positive airway pressure were recruited from San Gerardo Hospital, Monza, Italy. We collected baseline data on demographics, anthropometrics, arterial blood gas, and ventilation parameters. After baseline data collection, patients were helped into the prone position, which was maintained for a minimum duration of 3 h. Clinical data were re-collected 10 min after prone positioning and 1 h after returning to the supine position. The main study outcome was the variation in oxygenation (partial pressure of oxygen [PaO2]/fractional concentration of oxygen in inspired air [FiO2]) between baseline and resupination, as an index of pulmonary recruitment. This study is registered on ClinicalTrials.gov, NCT04365959, and is now complete.
FINDINGS: Between March 20 and April 9, 2020, we enrolled 56 patients, of whom 44 (79%) were male; the mean age was 57·4 years (SD 7·4) and the mean BMI was 27·5 kg/m2 (3·7). Prone positioning was feasible (ie, maintained for at least 3 h) in 47 patients (83·9% [95% CI 71·7 to 92·4]). Oxygenation substantially improved from supine to prone positioning (PaO2/FiO2 ratio 180·5 mm Hg [SD 76·6] in supine position vs 285·5 mm Hg [112·9] in prone position; p<0·0001). After resupination, improved oxygenation was maintained in 23 patients (50·0% [95% CI 34·9-65·1]; ie, responders); however, this improvement was on average not significant compared with before prone positioning (PaO2/FiO2 ratio 192·9 mm Hg [100·9] 1 h after resupination; p=0·29). Patients who maintained increased oxygenation had increased levels of inflammatory markers (C-reactive protein: 12·7 mg/L [SD 6·9] in responders vs 8·4 mg/L [6·2] in non-responders; and platelets: 241·1 × 103/μL [101·9] vs 319·8 × 103/μL [120·6]) and shorter time between admission to hospital and prone positioning (2·7 days [SD 2·1] in responders vs 4·6 days [3·7] in non-responders) than did those for whom improved oxygenation was not maintained. 13 (28%) of 46 patients were eventually intubated, seven (30%) of 23 responders and six (26%) of 23 non-responders (p=0·74). Five patients died during follow-up due to underlying disease, unrelated to study procedure.
INTERPRETATION: Prone positioning was feasible and effective in rapidly ameliorating blood oxygenation in awake patients with COVID-19-related pneumonia requiring oxygen supplementation. The effect was maintained after resupination in half of the patients. Further studies are warranted to ascertain the potential benefit of this technique in improving final respiratory and global outcomes.
FUNDING: University of Milan-Bicocca.
参考来源
- Coppo A, Bellani G, Winterton D, et al. Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study. Lancet Respir Med. 2020. PMID: 32569585. doi:10.1016/S2213-2600(20)30268-X
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。